Catherine J. Lee

Catherine J. Lee, MD

Languages spoken: English

Academic Information

Departments Adjunct - Internal Medicine

Divisions: Hematology & Hematologic Malignancies

Board Certification

  • American Board of Internal Medicine (Sub: Medical Oncology)
  • American Board of Internal Medicine (Sub: Hematology)

Catherine J. Lee, MD is an Associate Professor of Medicine in the Division of Hematology/BMT at the Huntsman Cancer Center, University of Utah.

Dr. Catherine Lee's clinical expertise is in Blood and Marrow Transplantation (BMT) & Cellular Therapy. She specializes in autologous and allogeneic hematopoietic cell transplants for the treatment of malignant and benign hematologic diseases in adult patients. She also directs the clinical cellular therapy program and provides both standard-of-care cellular therapy treatments and those being tested in clinical trials. Furthermore, she leads the Chronic Graft-versus-Host Disease/Long-Term Follow-Up Program for patients who have received hematopoietic cell transplantation or other immune-cellular therapies. This program is designed to monitor the health and quality of life of patients after transplant, and also provides medical care specific to patients with chronic GVHD and late effects of hematopoietic cell transplantation or other cellular therapies. Her research portfolio includes design of clinical trials for chronic GVHD, implementation of interventions to improve access to high-quality BMT care, and optimizing the health of post-transplant/cellular therapy patients. She is also the local principal investigator for clinical trials surrounding CAR-T cell therapy, post-transplant maintenance strategies to prevent AML relapse, and novel conditioning regimens for MDS/AML. She is an active member of the American Society for Transplantation and Cellular Therapy (ASTCT), ASTCT Survivorship Special Interest Group, BMT CTN Steering Committee Member of the Toxicity and Supportive Care Committee, and the National Marrow Donor Program/Be The Match member of the Featured Trial Review Committee for the Jason Carter Clinical Trials Search and Support (CTSS).

Education History

Undergraduate Johns Hopkins University
 BA
Professional Medical New York University School of Medicine
 MD
Fellowship Memorial Sloan Kettering Cancer Center
 Fellow
Fellowship University of Pittsburgh Cancer Institute
 Fellow
Fellowship Fred Hutchinson/SCCA Blood and Marrow Transplant Program
 Visiting Fellow
Fellowship Stanford School of Medicine
 Fellow

Selected Publications

Journal Article

  1. Lee CJ, Labopin M, Beelen D, Finke J, Blaise D, Ganser A, Itälä-Remes M, Chevallier P, Labussière-Wallet H1, Maertens J, Yakoub-Agha I, Bourhis JH, Mailhol A, Mohty M, Savani BN, Nagler A (2018). Comparative outcomes of myeloablative and reduced-intensity conditioning allogeneic hematopoietic cell transplantation for therapy-related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantation. Am J Hematol, 94(4), 431-438.
  2. Ariztia EV, Lee CJ, Gogoi R, Fishman D (2006). The tumor microenvironment: key to early detection. Critical reviews in clinical laboratory sciences, 43(5-6), 393-425. (Read full article)
  3. Lee CJ, Ariztia EV, Fishman D (2007). Conventional and proteomic technologies for the detection of early stage malignancies: markers for ovarian cancer. Critical reviews in clinical laboratory sciences, 44(1), 87-114. (Read full article)
  4. Lee CJ, Ansell J (2011). Direct thrombin inhibitors. British journal of clinical pharmacology, 72(4), 581-92. (Read full article)
  5. Lee CJ, Pusic I, Savani B (2021). Beyond ruxolitinib in steroid-refractory acute graft-versus-host disease. British journal of haematology, 195(3), 306-307. (Read full article)
  6. Ocier K, Abdelaziz S, Kim S, Rowe K, Snyder J, Deshmukh VG, Newman M, Fraser A, Smith KR, Porucznik CA, Shoaf K, Stanford JB, Lee CJ, Hashibe (2021). Age-Related Disease Risks in Younger versus Older B-Cell Non-Hodgkin's Lymphoma Survivors. Cancer epidemiology, biomarkers & prevention, 30(12), 2268-2277. (Read full article)
  7. Lee CJ, Shiraz P, Muffly (2017). Pharmacologic maintenance strategies following allogeneic hematopoietic cell transplantation for acute myeloid leukemia. Leukemia & lymphoma, 58(3), 516-527. (Read full article)
  8. Lee CJ, Savani BN, Mohty M, Gorin NC, Labopin M, Ruggeri A, Schmid C, Baron F, Esteve J, Giebel S, Ciceri F, Nagler A (2018). Post-remission strategies for the prevention of relapse following allogeneic hematopoietic cell transplantation for high-risk acute myeloid leukemia: Expert review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone marrow transplantation, 54(4), 519-530.
  9. Yoshihiro Inamoto, Igor Petricek, Linda Burns, Saurabh Chhabra, Zachariah DeFilipp, Peiman Hematti, Alicia Rovó, Raquel Schears, Ami Shah, Vaibhav Agrawal, Aisha Al Khinji, Ibrahim Ahmed, Asim Ali, Mahmoud D Aljurf, Hassan Alkhateeb, Amer Beitinjaneh, Neel Bhatt, David Buchbinder, Michael Byrne, Natalie Callander, Kristina Fahnehjelm, Nosha Farhadfar, Robert Gale, Siddhartha Ganguly, Gerhard Hildebrandt, Erich Horn, Ann Jakubowski, Rammurti Kamble, Jason Law, Lee CJ, Sunita Nathan, Olaf Penack, Sai Pingali, Pinki Prasad, Drazen Pulanic, Seth Rotz, Aditya Shreenivas, Amir Steinberg, KF Tabbara, André Tichelli, Baldeep Wirk, Jean Yared, Grzegorz Basak, Minnoo Battiwalla, Rafael Duarte, BipinSavani, Mary Flowers, Bronwen Shaw, and Nuria Valdés-San (2018). Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Bone marrow transplantation, 54(5), 648-661.
  10. Buchbinder D, Kelly DL, Duarte RF, Auletta JJ, Bhatt N, Byrne M, DeFilipp Z, Gabriel M, Mahindra A, Norkin M, Schoemans H, Shah AJ, Ahmed I, Atsuta Y, Basak GW, Beattie S, Bhella S, Bredeson C, Bunin N, Dalal J, Daly A, Gajewski J, Gale RP, Galvin J, Hamadani M, Hayashi RJ, Adekola K, Law J, Lee CJ, Liesveld J, Malone AK, Nagler A, Naik S, Nishihori T, Parsons SK, Scherwath A, Schofield HL, Soiffer R, Szer J, Twist I, Warwick AB, Wirk BM, Yi J, Battiwalla M, Flowers MDE, Savani B, Shaw B (2018). Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT. Bone marrow transplantation, 53(5), 535-555.
  11. Lee CJ, Savani BN, Mohty M, Gorin NC, Labopin M, Ruggeri A, Schmid C, Baron F, Esteve J, Giebel S, Ciceri F, Nagler (2019). Post-remission strategies for the prevention of relapse following allogeneic hematopoietic cell transplantation for high-risk acute myeloid leukemia: expert review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone marrow transplantation, 54(4), 519-530. (Read full article)
  12. Inamoto Y, Valdés-Sanz N, Ogawa Y, Alves M, Berchicci L, Galvin J, Greinix H, Hale GA, Horn B, Kelly D, Liu H, Rowley S, Schoemans H, Shah A, Lupo Stanghellini MT, Agrawal V, Ahmed I, Ali A, Bhatt N, Byrne M, Chhabra S, DeFilipp Z, Fahnehjelm K, Farhadfar N, Horn E, Lee C, Nathan S, Penack O, Prasad P, Rotz S, Rovó A, Yared J, Pavletic S, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Petri'ek (2019). Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Bone marrow transplantation, 54(5), 662-673. (Read full article)
  13. Krishnan R, Pangilinan F, Lee C, Spencer (2000). Saccharomyces cerevisiae BUB2 prevents mitotic exit in response to both spindle and kinetochore damage. Genetics, 156(2), 489-500. (Read full article)
  14. Smicun Y, Reierstad S, Wang FQ, Lee C, Fishman D (2006). S1P regulation of ovarian carcinoma invasiveness. Gynecologic oncology, 103(3), 952-9. (Read full article)
  15. Gil OD, Lee C, Ariztia EV, Wang FQ, Smith PJ, Hope JM, Fishman D (2008). Lysophosphatidic acid (LPA) promotes E-cadherin ectodomain shedding and OVCA429 cell invasion in an uPA-dependent manner. Gynecologic oncology, 108(2), 361-9. (Read full article)
  16. Lee CJ, Savani BN, Mohty M, Labopin M, Ruggeri A, Schmid C, Baron F, Esteve J, Gorin NC, Giebel S, Ciceri F, Nagler (2017). Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Haematologica, 102(11), 1810-1822. (Read full article)
  17. Lee CJ, Badhwar G, Ansell J (2010). Oral IIa inhibitors. Hematology/oncology clinics of North America, 24(4), 739-53, ix. (Read full article)
  18. Couriel DR, Ricker H, Steinbach M, Lee C (2016). Neurologic Manifestations of Blood Dyscrasias. Hematology/oncology clinics of North America, 30(4), 723-31. (Read full article)
  19. Kudla MJ, Timor-Tritsch IE, Hope JM, Monteagudo A, Popiolek D, Monda S, Lee CJ, Arslan A (2008). Spherical tissue sampling in 3-dimensional power Doppler angiography: a new approach for evaluation of ovarian tumors. Journal of ultrasound in medicine, 27(3), 425-33. (Read full article)
  20. Barnes CA, Stout NL, Varghese TK Jr, Ulrich CM, Couriel DR, Lee CJ, Noren CS, LaStayo P (2020). Clinically Integrated Physical Therapist Practice in Cancer Care: A New Comprehensive Approach. Physical therapy, 100(3), 543-553. (Read full article)
  21. Kelly DL, Buchbinder D, Duarte RF, Auletta JJ, Bhatt N, Byrne M, Gabriel M, Mahindra A, Norkin M, Schoemans H, Shah AJ, Ahmed I, Atsuta Y, Basak GW, Beattie S, Bhella S, Bredeson C, Bunin N, Dalal J, Daly A, Gajewski J, Gale RP, Galvin J, Hamadani M, Hayashi RJ, Adekola K, Law J, Lee CJ, Liesveld J, Malone AK, Nagler A, Naik S, Nishihori T, Parsons SK, Scherwath A, Schofield HL, Soiffer R, Szer J, Twist I, Warwick A, Wirk BM, Yi J, Battiwalla M, Flowers ME, Savani B, Shaw B (2018). Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review From the Late Effects and Quality of Life Working Committee of the CIBMTR and Complications and Quality of Life Working Party of the EBMT. Biology of blood and marrow transplantation, 24(2), 228-241.
  22. Yoshihiro Inamoto, Nuria Valdés-Sanz, Yoko Ogawa, Monica Alves, Luigi Berchicci, John Galvin, Hildegard Greinix, Gregory Hale, Biljana Horn, Debra Kelly, Hien Liu, Scott Rowley, Helene Schoemans, Ami Shah, Maria Stanghellini, Vaibhav Agrawal, Ibrahim Ahmed, Asim Ali, Neel Bhatt, Michael Byrne, Saurabh Chhabra, Zachariah DeFilipp, Kristina Fahnehjelm, Nosha Farhadfar, Erich Horn, Lee CJ, Sunita Nathan, Olaf Penack, Pinki Prasad, Seth Rotz, Alicia Rovó, Jean Yared, Steven Pavletic, Grzegorz Basak, Minnoo Battiwalla, Rafael Duarte, Bipin Savani, Mary Flowers, Bronwen Shaw, and Igor Petrice (2018). Ocular graft-versus-host disease after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Biology of blood and marrow transplantation, 25(2), e46-e54.
  23. Radojcic V, Lee CJ, Couriel D (2018). Multifaceted Burden of Chronic Graft-versus-Host Disease. Biology of blood and marrow transplantation, 24(9), 1774-1775. (Read full article)
  24. Lee CJ, Savani BN, Ljungman (2018). Varicella Zoster Virus Reactivation in Adult Survivors of Hematopoietic Cell Transplantation: How Do We Best Protect Our Patients?. Biology of blood and marrow transplantation, 24(9), 1783-1787. (Read full article)
  25. Im A, Rashidi A, Wang T, Hemmer M, MacMillan ML, Pidala J, Jagasia M, Pavletic S, Majhail NS, Weisdorf D, Abdel-Azim H, Agrawal V, Al-Homsi AS, Aljurf M, Askar M, Auletta JJ, Bashey A, Beitinjaneh A, Bhatt VR, Byrne M, Cahn JY, Cairo M, Castillo P, Cerny J, Chhabra S, Choe H, Ciurea S, Daly A, Perez MAD, Farhadfar N, Gadalla SM, Gale R, Ganguly S, Gergis U, Hanna R, Hematti P, Herzig R, Hildebrandt GC, Lad DP, Lee C, Lehmann L, Lekakis L, Kamble RT, Kharfan-Dabaja MA, Khandelwal P, Martino R, Murthy HS, Nishihori T, O'Brien TA, Olsson RF, Patel SS, Perales MA, Prestidge T, Qayed M, Romee R, Schoemans H, Seo S, Sharma A, Solh M, Strair R, Teshima T, Urbano-Ispizua A, Van der Poel M, Vij R, Wagner JL, William B, Wirk B, Yared JA, Spellman SR, Arora M, Hamilton B (2020). Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide. Biology of blood and marrow transplantation, 26(8), 1459-1468. (Read full article)
  26. Inamoto Y, Petri'ek I, Burns L, Chhabra S, DeFilipp Z, Hematti P, Rovó A, Schears R, Shah A, Agrawal V, Ahmed A, Ahmed I, Ali A, Aljurf M, Alkhateeb H, Beitinjaneh A, Bhatt N, Buchbinder D, Byrne M, Callander N, Fahnehjelm K, Farhadfar N, Gale RP, Ganguly S, Hashmi S, Hildebrandt GC, Horn E, Jakubowski A, Kamble RT, Law J, Lee C, Nathan S, Penack O, Pingali R, Prasad P, Pulanic D, Rotz S, Shreenivas A, Steinberg A, Tabbara K, Tichelli A, Wirk B, Yared J, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Valdés-Sanz (2019). Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation. Biology of blood and marrow transplantation, 25(5), e145-e154. (Read full article)
  27. Inamoto Y, Valdés-Sanz N, Ogawa Y, Alves M, Berchicci L, Galvin J, Greinix H, Hale GA, Horn B, Kelly D, Liu H, Rowley S, Schoemans H, Shah A, Lupo Stanghellini MT, Agrawal V, Ahmed I, Ali A, Bhatt N, Byrne M, Chhabra S, DeFilipp Z, Fahnehjelm K, Farhadfar N, Horn E, Lee C, Nathan S, Penack O, Prasad P, Rotz S, Rovó A, Yared J, Pavletic S, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Petri'ek (2019). Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. Biology of blood and marrow transplantation, 25(2), e46-e54. (Read full article)
  28. Lee CJ, Muffly L (2017). Coordination of Care in Survivorship After Treatment of Hematological Malignancies-The Journey is Not Over Yet. Current hematologic malignancy reports, 12(4), 317-323.
  29. Lee CJ, Muffly L (2017). Coordination of Care in Survivorship After Treatment of Hematological Malignancies-The Journey is Not Over Yet. Current hematologic malignancy reports, 12(4), 317-323. (Read full article)
  30. Ocier K, Abdelaziz S, Kim S, Rowe K, Snyder J, Deshmukh V, Newman M, Fraser A, Smith K, Porucznik CA, Shoaf K, Stanford JB, Lee CJ, Hashibe (2021). Cardiovascular disease risks in younger versus older adult B-cell non-Hodgkin's lymphoma survivors. Cancer medicine, 10(12), 4117-4126. (Read full article)
  31. Lee CJ, Kim S, Tecca HR, Bo-Subait S, Phelan R, Brazauskas R, Buchbinder D, Hamilton BK, Battiwalla M, Majhail NS, Lazarus HM, Shaw PJ, Marks DI, Litzow MR, Chhabra S, Inamoto Y, DeFilipp Z, Hildebrandt GC, Olsson RF, Kasow KA, Liesveld JL, Rotz SJ, Badawy SM, Bhatt NS, Yared JA, Page KM, Arellano ML, Kent M, Farhadfar N, Seo S, Hematti P, Freytes CO, Rovó A, Ganguly S, Nathan S, Burns L, Shaw BE, Muffly L (2020). Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia. Blood advances, 4(6), 983-992. (Read full article)
  32. Bhatt NS, Brazauskas R, Salit RB, Syrjala K, Bo-Subait S, Tecca H, Badawy SM, Baker KS, Beitinjaneh A, Bejanyan N, Byrne M, Dias A, Farhadfar N, Freytes CO, Ganguly S, Hashmi S, Hayashi RJ, Hong S, Inamoto Y, Jamani K, Kasow KA, Khera N, Krem MM, Lazarus HM, Lee CJ, Lee S, Majhail NS, Malone AK, Marks DI, Mau LW, Mayo SJ, Muffly LS, Nathan S, Nishihori T, Page KM, Preussler J, Rangarajan HG, Rotz SJ, Salooja N, Savani BN, Schears R, Schechter-Finkelstein T, Schiller G, Shah AJ, Sharma A, Wang T, Wirk B, Battiwalla M, Schoemans H, Hamilton B, Buchbinder D, Phelan R, Shaw (2021). Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States. Transplantation and cellular therapy, 27(8), 679.e1-679.e8. (Read full article)
  33. Fennell K, Keller MA, Villa MA, Paccapelo C, Kucerakova M, Rosochova J, Clemente DosSantos C, Brackney L, Lee CJ, Metcalf R, Crovetti G, Barbieri M, Travali S, Barrotta G, Giuca G, Guerra LE, Ochoa-Garay (2021). New ABO intron 1 variant alleles. Immunohematology, 37(4), 178-184. (Read full article)
  34. Peoples AR, Oswald LB, Ose J, Daniels B, Himbert C, Hathaway CA, Gigic B, Kirchhoff AC, Lin T, Grossman D, Tward J, Varghese TK Jr, Figueiredo JC, Toriola AT, Beck A, Scaife C, Shibata D, LaStayo P, Gonzalez B, Salas K, Ashworth A, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich C (2022). Impact of the COVID-19 pandemic on rural and urban cancer patients' experiences, health behaviors, and perceptions. The Journal of rural health, 38(4), 886-899. (Read full article)
  35. Lee CJ, Wang T, Chen K, Arora M, Brazauskas R, Spellman SR, Kitko C, MacMillan ML, Pidala JA, Auletta JJ, Badawy SM, Bhatt N, Bhatt VR, Cahn JY, DeFilipp Z, Diaz MA, Farhadfar N, Gadalla S, Gale RP, Hashem H, Hashmi S, Hematti P, Hong S, Hossain NM, Inamoto Y, Lekakis LJ, Modi D, Patel S, Sharma A, Solomon S, Couriel D (2022). Association of Chronic Graft-versus-Host Disease with Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy. Transplantation and cellular therapy, 28, 712.e1-712.e8. (Read full article)
  36. Himbert C, Hathaway CA, Daniels B, Salas K, Ashworth A, Gigic B, Lin T, Viskochil R, Kirchhoff AC, Grossman D, Ose J, Tward J, Scaife C, Figueiredo JC, Toriola AT, Beck A, Shibata D, Gonzalez BD, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM, Peoples A (2022). Factors associated with changes in exercise behaviors during the COVID-19 pandemic. Cancer causes & control, 33(7), 939-950. (Read full article)
  37. Tao R, Chen Y, Kim S, Ocier K, Lloyd S, Poppe MM, Lee CJ, Glenn MJ, Smith KR, Fraser A, Deshmukh V, Newman MG, Snyder J, Rowe KG, Gaffney DK, Haaland B, Hashibe (2022). Mental health disorders are more common in patients with Hodgkin lymphoma and may negatively impact overall survival. Cancer, 128(19), 3564-3572. (Read full article)
  38. Lloyd J, Lee C (2022). Use of Telemedicine in Care of Hematologic Malignancy Patients: Challenges and Opportunities. Current hematologic malignancy reports, 17(1), 25-30.
  39. Ocier K, Abdelaziz S, Kim S, Rowe K, Snyder J, Deshmukh V, Newman M, Fraser A, Smith K, Porucznik C, Shoaf K, Stanford J, Lee C, Hashibe (2022). Contributions of cancer treatment, comorbidities, and obesity to aging-related disease risks among non-Hodgkin lymphoma survivors. Cancer causes & control, (Read full article)
  40. Ocier K,Abdelaziz S,Kim S,Rowe K,Snyder J,Deshmukh V,Newman M,Fraser A,Smith K,Porucznik C,Shoaf K,Stanford J,Lee C,Hashibe (2022). Contributions of cancer treatment, comorbidities, and obesity to aging-related disease risks among non-Hodgkin lymphoma survivors. Cancer causes & control, 34(2), 171-180. (Read full article)
  41. Lee CJ,Labopin M,Beelen D,Finke J,Blaise D,Ganser A,Itälä-Remes M,Chevallier P,Labussière-Wallet H,Maertens J,Yakoub-Agha I,Bourhis JH,Mailhol A,Mohty M,Savani BN,Nagler (2019). Comparative outcomes of myeloablative and reduced-intensity conditioning allogeneic hematopoietic cell transplantation for therapy-related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantation. American journal of hematology, 94(4), 431-438. (Read full article)

Review

  1. Lloyd J, Lee C (2022). Use of Telemedicine in Care of Hematologic Malignancy Patients: Challenges and Opportunities. Current hematologic malignancy reports, 17(1), 25-30. (Read full article)
  2. Inamoto Y,Petri'ek I,Burns L,Chhabra S,DeFilipp Z,Hematti P,Rovó A,Schears R,Shah A,Agrawal V,Al-Khinji A,Ahmed I,Ali A,Aljurf M,Alkhateeb H,Beitinjaneh A,Bhatt N,Buchbinder D,Byrne M,Callander N,Fahnehjelm K,Farhadfar N,Gale RP,Ganguly S,Hildebrandt GC,Horn E,Jakubowski A,Kamble RT,Law J,Lee C,Nathan S,Penack O,Pingali R,Prasad P,Pulanic D,Rotz S,Shreenivas A,Steinberg A,Tabbara K,Tichelli A,Wirk B,Yared J,Basak GW,Battiwalla M,Duarte R,Savani BN,Flowers MED,Shaw BE,Valdés-Sanz (2019). Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Bone marrow transplantation, 54(5), 648-661. (Read full article)

Book

  1. Lee CJ, Miller E (2012). Deja Review: Obstetrics and Gynecology.
  2. Lee CJ, Miller E (2008). Deja Review: Obstetrics and Gynecology.

Book Chapter

  1. Lee C (2006). Female Reproductive Tract. 115-25.
  2. Nguyen A and Lee C (2018). Immunodeficiency-associated Lymphoproliferative Disorders.
  3. Catherine J. Lee, Mihkaila Wickline, and Mary E.D. Flower (2021). Telemedicine in patient care of long-term transplant survivors.

Conference Proceedings

  1. Lee CJ, Kane L (2014). Expression and function of tim-3, a potential therapeutic target in acute myeloid leukemia. Journal of clinical oncology, 32(5s(suppl; abstr 7095)),

Letter

  1. Radojcic V, Pletneva M, Lee CJ, Ivcevic S, Sarantopoulos S, Couriel (2021). Hedgehog blockade in steroid-refractory sclerotic chronic graft-versus-host disease. British journal of haematology, 195(2), e120-e122. (Read full article)
  2. Baron MK, Osborn JD, Tao R, Lee C (2020). Haploidentical hematopoietic cell transplantation for mycosis fungoides/Sezary syndrome. Leukemia & lymphoma, 61(1), 231-233. (Read full article)
  3. Osborn JD, Cariello PF, Pena E, Lee C (2020). Nocardia thyroiditis after allogeneic hematopoietic cell transplantation. Leukemia & lymphoma, 61(4), 983-986. (Read full article)
  4. Trunk AD, Shewan SK, Lee CJ, Parker CJ, Couriel D (2022). Chronic graft-versus-host disease exacerbation after SARS-CoV-2 vaccination. Bone marrow transplantation, 57(3), 502-503. (Read full article)

Abstract

  1. Lee CJ, Soyoung Kim, Heather R. Tecca, Ruta Brazauskas, Minoo Battiwalla, David K. Buchbinder, Mary E. D. Flowers, Rachel Phelan, Bronwen E. Shaw and Lori S Muffly (01/14/2019). Impact of Myeloablative Total Body Irradiation Versus Chemotherapy on Late Effects and Survival Among Adolescent and Young Adult Survivors of Hematopoietic Cell Transplantation for Acute Leukemia: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis [Abstract]. Blood, 132.
  2. Derek K Chang, Jihye Park, Yuan Wan, Alison Fraser, Kerry Rowe, John Snyder, Vikrant Deshmukh, Michael Newman, Kimberly Herget, Ken Smith, Mia Hashibe and Lee CJ (01/14/2019). Increased Risk of Diabetes Mellitus Among Adult Survivors of B-Cell Non-Hodgkin Lymphoma [Abstract]. Blood, 132.
  3. Lee CJ, Myriam Labopin, Dietrich Beelen, Jürgen Finke, Didier Blaise, Arnold Ganser, Maija Itälä-Remes, Patrice Chevallier, Hélène Labussière-Wallet, MD, PhD, Johan Maertens, Ibrahim Yakoub-Agha, Jean-Henri Bourhis, Audrey Mailhol, Mohamed Mohty, Bipin Savani, Arnon Nagle (2018). Superior Outcomes With Myeloablative Versus Reduced-Intensity Conditioning Allogeneic Hematopoetic Cell Transplantation for Secondary Acute Myeloid Leukemia with Prior Solid Tumor: An ALWP of EBMT Study. Bone marrow transplantation,
  4. Barnes, Christopher, Lee CJ, Rushton, Ryan J , Osborn, James D, Sweetser, Erin, Gaillard, Jeramie, Marcus, Robin L, Noren, Christopher S, Couriel, Daniel R, LaStayo, Pau (2018). Assessing and Intervening to Improve Mobility for People with Post-Acute Hematopoietic Cell Transplant: A Quality Improvement Project. Biology of blood and marrow transplantation, 24(3(supp1)), S269.
  5. Lee CJ, et a (2018). Myeloablative, Intravenous Busulfan-Based Regimen Prior to Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancies Is Safe and Effective in Patients Age 60 and Older. Biology of blood and marrow transplantation, 24(3(supp1)), S332.
  6. Lee CJ, et a (2018). Impact of Geographic and Socioeconomic Factors (SEF) on Long-Term Hematopoietic Stem Cell Transplant (HSCT) Outcomes. Biology of blood and marrow transplantation, 24(3(supp1)), S222.
  7. Lee CJ, Ariztia EV, Fishman D (2007). Lysophosphatidic acid (LPA) regulates cell surface expression of e-cadherin in ovarian carcinoma cells; also presented as a poster at 2007 Scientific Annual Meeting of the Society for Gynecologic Investigation 3/14-17/2007, Reno, NV. Reproductive sciences (Thousand Oaks, Calif.), 14(1), 173a.
  8. Barnes, Christopher, Lee CJ, Rushton, Ryan J, Osborn, James D, Sweetser, Erin, Gaillard, Jeramie, Marcus, Robin L, Noren, Christopher S, LaStayo, Paul, Couriel, Daniel (2018). Use of a Patient-Reported Physical Function Measure Allows Clinically- Pragmatic, Individually-Tailored Exercise Interventions for People with Chronic Graft- Versus-Host Disease.
  9. Christopher Barnes, Nicole L Stout, Thomas K Varghese Jr., Cornelia M Ulrich, Daniel R Couriel, Lee CJ, Christopher S Noren, and Paul C LaStay (2018). A Clinically-Integrated Physical Therapist Model to Implement Cancer Rehabilitation Best Practices.
  10. Michael T. Byrne, Tony J Kurian, Dilan A Patel, Roni Tamari, Sanghee Hong, Haitham Abdelhakim, Victoria Klein, Patricio Rojas, Raksha Madhavan, Andrew Kent, Aaron C. Logan, Catherine J. Lee, Muhammad Husnain, Benjamin M Manning, Nicholas P. Tschernia, Ajoy L. Dias, Daniel Margalski, Benjamin Goldenson, Nathalie Byrne, Heidi Chen, Kseniya Petrova-Drus, Salyka M. Sengsayadeth, Aaron M Goodman, Dianna S. Howard, William A. Wood, Saar Gill, Antonio M. Jimenez, Jonathan A. Gutman, Lohith Gowda, Leland Metheny, III, Bhavana Bhatnagar, Betty K. Hamilton, Asmita Mishra, Michael R. Savon (2021). Non-relapse Mortality in TP53-Mutated MDS/AML - Multi-Center Collaborative Study. 138 (Supplement 1), 2922.
  11. Andrew D. Trunk, Samuel Shewan, Catherine J. Lee, Daniel R. Courie (2022). Chronic Graft-Versus Host Disease (cGVHD) Exacerbation after Sars-Cov-2 Covid Vaccination. 138((Supplement 1)), 1813.
  12. Erin Sweetser, Daniel Couriel, Catherine Lee, Christopher Barnes, Christopher Noren, Kayla Woodring, Ed Wicklande (2020). Functional Outcome measures in Hematopoietic Stem Cell Transplant (HSCT): Focus on the 2-Minute Walk Test. The 46th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Oral session (O010-O173). 55((Supplement 1)), 22-174.
  13. Catherine J. Lee, Tao Wang, Karen Chen, Stephen R. Spellman, Carrie Lynn Kitko, Margaret L. MacMillan, Joseph A. Pidala, Jeffery J. Auletta, Sherif Badawy, Minoo Battiwalla, Vijaya Raj Bhatt, David Buchbinder, Jean-Yves Cahn, Zachariah DeFilipp, Miguel Angel Diaz, Nosha Farhadfar, Shahinaz M Gadalla, Robert Peter Gale, Hasan Hashem, Shahrukh K. Hashmi, Peiman Hematti, Sanghee Hong, Nasheed Hossain, Yoshihiro Inamoto, Rammurti T. Kamble, Anita Kumar, Lazaros J. Lekakis, Dipenkumar Modi, Sagar Patel, Bipin Savani, Akshay Sharma, Scott R. Solomon, Leo Verdonck, Mukta Arora, Daniel R. Couriel (2021). Impact of Chronic Graft-Versus-Host Disease on First late Effect Among Adult Survivors of Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplantation Research (CIMBTR) Analysis. 27(3, Supplement), S39-S40.
  14. Catherine J. Lee, Tao Wang, Karen Chen, Stephen R. Spellman, Carrie Lynn Kitko, Margaret L. MacMillan, Joseph A. Pidala, Jeffery J. Auletta, Sherif Badawy, Minoo Battiwalla, Vijaya Raj Bhatt, David Buchbinder, Jean-Yves Cahn, Zachariah DeFilipp, Miguel Angel Diaz, Nosha Farhadfar, Shahinaz M Gadalla, Robert Peter Gale, Hasan Hashem, Shahrukh K. Hashmi, Peiman Hematti, Sanghee Hong, Nasheed Hossain, Yoshihiro Inamoto, Rammurti T. Kamble, Anita Kumar, Lazaros J. Lekakis, Dipenkumar Modi, Sagar Patel, Bipin Savani, Akshay Sharma, Scott R. Solomon, Leo Verdonck, Mukta Arora, Daniel R. Courie (2021). First Lake effect in Pediatric Survivors with Chronic Graft-Versus-Host Disease Following Hematopoietic Cell Transplantation for Hematologic Malignancy. 27(3, Supplement), S40-S42.
  15. Michael Byrne, Tony Kurian, Dilan Patel, Roni Tamari, Sanghee Hong, Haitham Abdelhakim, Victoria Klein, Patricio Rojas, Raksha Madhavan, Andrew Kent, Aaron C. Logan, Catherine J. Lee, Muhammad Husnain, Benjamin Manning, Nicholas Tschernia, Ajoy Dias, Daniel Margalski, Benjamin Goldenson, Nathalie D. Byrne, Heidi Chen, Kseniya Petrova-Drus, Salyka Sengsayadeth, Aaron Goodman, Dianna S. Howard, William A. Wood, Saar Gill, Antonio Jimenez Jimenez, Jonathan A. Gutman, Lohith Gowda, Leland Metheny III, Bhavana Bhatnagar, Betty K. Hamilton, Asmita Mishra, Michael R. Savon (2021). A Multi-Center Collaborative Study of Outcomes of TP53-Mutated MDS/AML Patients Following Allogeneic HCT. 28(3, Supplement), S40-S41.
  16. Seth J Rotz, Betty K. Hamilton, Jane Koo, Rawan Nawabit, Christina S Ferraro, Nahal Lalefar, Lauren A Stafford, Livia Caroline Barbosa Mariano, Sameeya Ahmed-Winston, Rachel Phelan, Alexander Ngwube, Catherine J. Lee, Stacy Whiteside, Nicholas J. Gloude, Kasiani C. Myer (2022). 505-Assessment of Fertility Potential and Gonadal Function in Survivors of Reduced Intensity Hematopoietic Cell Transplantation. 28(3, Supplement), S392-S393.
  17. Lori Muffly, Catherine J. Lee, Arpita Gandhi, Ankur Varma, Bart L. Scott, Hye-Sook Kwon, Chikako Yanagiba, Jeyakavitha Arulprakasam, Mamatha Reddy, Kevin N. Heller, Judith A. Shizuru, Wendy W. Pang, Andrew Art (2022). LBA4 - Preliminary Data from a Phase 1 Study of JSP191, an Anti-CD117 Monoclonal Antibody, in Combination with Low Dose Irradiation and Fludarabine Conditioning Is Well-Tolerated, Facilitates Chimerism and Clearance of Minimal Residual Disease in Older Adults with MDS/AML Undergoing Allogeneic HCT. 28(3, Supplement), S476-S478.
  18. Frederick L. Locke, Justin Chou, Saran Vardhanabhuti, Regis Perbost, Peter Dreger, Brian T Hill, Catherine Lee, Pier Luigi Zinzani, Nicolaus Kroeger, Armando López-Guillermo, Hildegard Greinix, Wangshu Zhang, Gayatri Tiwari, Christina Ann To, Paul C. Cheng, Adrian Bot, Rhine Shen, Simone Filosto, Jerome Galo (2022). Association of pretreatment (preTX) tumor characteristics and clinical outcomes following second-line (2L) axicabtagene ciloleucel (axi-cel) versus standard use of care (SOC) in patients (pts) with relapsed/refractory (R/R) large B-Cell lymphoma (LBCL). 40(Supplement 16), abstract 7565.

Newspaper

  1. Lee C (2019). Is home-based remote monitoring ready for prime time in oncology?.

Other

  1. Inamoto Y, Petri'ek I, Burns L, Chhabra S, DeFilipp Z, Hematti P, Rovó A, Schears R, Shah A, Agrawal V, Al-Khinji A, Ahmed I, Ali A, Aljurf M, Alkhateeb H, Beitinjaneh A, Bhatt N, Buchbinder D, Byrne M, Callander N, Fahnehjelm K, Farhadfar N, Gale RP, Ganguly S, Hildebrandt GC, Horn E, Jakubowski A, Kamble RT, Law J, Lee C, Nathan S, Penack O, Pingali R, Prasad P, Pulanic D, Rotz S, Shreenivas A, Steinberg A, Tabbara K, Tichelli A, Wirk B, Yared J, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Valdés-Sanz (2019). Correction: Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Bone marrow transplantation, 54(5), 782-783. (Read full article)
  2. Himbert C, Hathaway CA, Daniels B, Salas K, Ashworth A, Gigic B, Lin T, Viskochil R, Kirchhoff AC, Grossman D, Ose J, Tward J, Scaife C, Figueiredo JC, Toriola AT, Beck A, Shibata D, Gonzalez BD, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM, Peoples A (2021). Impact of the COVID-19 pandemic on exercise habits among cancer patients. (Read full article)

Video/Film/CD/Web/Podcast

  1. Daniel Kiefer, MD and Ashley Roman, MD, MPH, Lee CJ, (acknowledged for manuscript drafting (2007). Management of hematomas incurred as a result of obstetrical deliveries.
  2. Catherine J. Le (2021). Season 6 of Marrow Masters Podcast: All Things Graft vs. Host Disease.